CONTI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 630
EU - Europa 349
AS - Asia 196
AF - Africa 8
OC - Oceania 3
Totale 1.186
Nazione #
US - Stati Uniti d'America 624
IT - Italia 204
SG - Singapore 88
CN - Cina 81
NL - Olanda 45
IE - Irlanda 28
FI - Finlandia 21
UA - Ucraina 19
IN - India 12
VN - Vietnam 12
DE - Germania 9
FR - Francia 9
CI - Costa d'Avorio 8
CA - Canada 6
GB - Regno Unito 6
NZ - Nuova Zelanda 3
BE - Belgio 2
PL - Polonia 2
ES - Italia 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
RO - Romania 1
SE - Svezia 1
SI - Slovenia 1
Totale 1.186
Città #
Chandler 140
Singapore 74
Amsterdam 38
Ashburn 38
Naples 30
Napoli 30
Beijing 28
Jacksonville 24
Millbury 23
Princeton 22
Nanjing 21
Woodbridge 20
Santa Clara 19
Boston 16
Des Moines 12
Dong Ket 12
Wilmington 12
Seattle 11
Formia 8
Lawrence 7
Genova 6
Ottawa 6
Pune 6
Milan 5
Caserta 4
Changsha 4
Dallas 4
Falls Church 4
Nanchang 4
Brest 3
Dearborn 3
Dunedin 3
Hebei 3
Jiaxing 3
Montesarchio 3
Rome 3
Boardman 2
Caivano 2
Castellammare di Stabia 2
Dublin 2
Eboli 2
Fairfield 2
Hangzhou 2
Indiana 2
New Delhi 2
New York 2
Peachtree Corners 2
Pomigliano D'arco 2
Pozzuoli 2
Redmond 2
Rosignano Marittimo 2
Salerno 2
Shanghai 2
Shenyang 2
Strasbourg 2
Tianjin 2
Waanrode 2
Acerra 1
Augusta 1
Baranzate 1
Cambridge 1
Campagna 1
Changchun 1
Cormeilles-en-Parisis 1
Ercolano 1
Frankfurt am Main 1
Godiasco 1
Guangzhou 1
Harrisonburg 1
Houston 1
Kitamachi 1
Kunming 1
Misterbianco 1
Mountain View 1
Munich 1
Newark 1
Nola 1
Norwalk 1
Palermo 1
Paris 1
Parma 1
Phoenix 1
Pompei 1
Prineville 1
Quarto 1
Redwood City 1
San Giovanni Rotondo 1
San Mango 1
Sant'antimo 1
Shefa-'Amr 1
Valladolid 1
Warsaw 1
Washington 1
Yeoncheon-gun 1
Totale 728
Nome #
Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells 79
Inverted duplication of 15q with terminal deletion in a multiple malformed newborn with intrauterine growth failure and lethal phenotype 62
First trimester ultrasound features of X-linked Opitz syndrome and early molecular diagnosis: case report and review of the literature 58
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets 56
Prenatal diagnosis of 22q11 microdeletion in a fetus with a conotruncal heart defect 53
40 Mb duplication in chromosome band 5p13.1p15.33 with 800 kb terminal deletion in a foetus with mild phenotypic features 49
Constitutional chromothripsis involving the critical region of 9q21.13 microdeletion syndrome 49
Targeting mitochondrial network architecture in down syndrome and aging 49
Overexpression of Chromosome 21 miRNAs May Affect Mitochondrial Function in the Hearts of Down Syndrome Fetuses 48
Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency 48
Human trisomic ipscs from down syndrome fibroblasts manifest mitochondrial alterations early during neuronal differentiation 47
Human miRNAs on chromosome 21 are differentially expressed in Down syndrome fetal hearts 44
Mild Wolf-Hirschhorn phenotype and partial GH deficiency in a patient with a 4p terminal deletion. 41
Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects 41
Short stature and primary ovarian insufficiency possibly due to chromosomal position effect in a balanced X;1 translocation 41
Selective cognitive impairment and tall stature due to chromosome 19 supernumerary ring. 39
Pioglitazone improves mitochondrial organization and bioenergetics in down syndrome cells 39
Gene Expression Profile in Liver Transplantation and the Influence of Gene Dysregulation Occurring in Deceased Donor Grafts 38
Variegated silencing of a large Xq region causes hypomelanosis of Ito phenotype in a case of balanced X;2 translocation. 36
Clinical Description of a Patient Carrying the Smallest Reported Deletion Involving 10p14 Region 35
Differential expression of human chromosome 21 miRNAs in Down syndrome fetal hearts 34
NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome 33
Prenatally diagnosed distal 16p11.2 microdeletion with a novel association with congenital diaphragmatic hernia: a case report 33
Variegated silencing throughepigenetic modifications of a large Xq region in a case of balanced X;2translocation with Incontinentia Pigmenti-like phenotype 32
Human miRNAs on chromosome 21 are differentially expressed in Down syndrome fetal hearts. 31
Trascriptome alterations and functional profiling of the heart of human fetuses with chromosome 21 trisomy. 30
Overexpression of the Hsa21 Transcription Factor RUNX1 Modulates the Extracellular Matrix in Trisomy 21 Cells 29
Down Syndrome Fetal Fibroblasts Display Alterations of Endosomal Trafficking Possibly due to SYNJ1 Overexpression 26
Identification of Novel Pax8 Targets in FRTL-5 Thyroid Cells by Gene Silencing and Expression Microarray Analysis 26
Short 9q interstitial deletion in a neonate with lethal non-immune hydrops. 21
Pure 16q21q22.1 deletion in a complex rearrangement possibly caused by a chromothripsis event. 21
Totale 1.268
Categoria #
all - tutte 5.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 16 2 2 1 5 21 17 8
2020/202190 1 3 7 5 13 11 6 0 19 4 9 12
2021/2022214 1 4 0 2 4 6 2 12 42 24 56 61
2022/2023324 33 17 20 27 41 30 6 41 53 39 13 4
2023/2024186 8 39 9 14 8 28 7 24 3 3 28 15
2024/2025150 59 22 14 9 46 0 0 0 0 0 0 0
Totale 1.268